Controls | Cases | OR1* | OR2** | 95% CI (OR2) | ||
---|---|---|---|---|---|---|
Study I | Population Controls | |||||
No exposure | 389 | 630 | 1.0 | 1.0 | (ref) | |
Any level of exposure | 144 | 227 | 0.8 | 0.7 | 0.5 | 1.0 |
Any level ≤ 20 years | 88 | 141 | 0.8 | 0.7 | 0.5 | 1.0 |
Any level > 20 years | 56 | 86 | 0.7 | 0.7 | 0.4 | 1.1 |
Non-substantial level | 74 | 113 | 0.8 | 0.7 | 0.5 | 1.0 |
Substantial level | 70 | 114 | 0.7 | 0.7 | 0.5 | 1.0 |
Study I | Cancer Controls | |||||
No exposure | 1072 | 630 | 1.0 | 1.0 | (ref) | |
Any level of exposure | 277 | 227 | 1.2 | 1.1 | 0.9 | 1.5 |
Any level ≤ 20 years | 179 | 141 | 1.2 | 1.1 | 0.8 | 1.5 |
Any level > 20 years | 98 | 86 | 1.2 | 1.2 | 0.8 | 1.7 |
Non-substantial level | 161 | 113 | 1.0 | 1.0 | 0.7 | 1.3 |
Substantial level | 116 | 114 | 1.5 | 1.4 | 1.0 | 2.0 |
Study II | Population Controls | |||||
No exposure | 640 | 501 | 1.0 | 1.0 | (ref) | |
Any level of exposure | 254 | 235 | 1.2 | 1.1 | 0.9 | 1.5 |
Any level ≤ 20 years | 165 | 139 | 1.1 | 1.0 | 0.8 | 1.4 |
Any level > 20 years | 89 | 96 | 1.4 | 1.3 | 0.9 | 1.9 |
Non-substantial level | 201 | 167 | 1.1 | 1.0 | 0.7 | 1.3 |
Substantial level | 53 | 68 | 1.9 | 1.7 | 1.1 | 2.7 |